In vitro screening for drug repositioning.

Area of Science:

• Pharmacology
• Drug Discovery
• Biotechnology

Background:

• Drug repositioning is a growing field, generating new intellectual property and investigational new drug submissions.
• Computational methods are trending for initial hypothesis generation, followed by biological activity assessment.
• In vitro screening of known drugs in phenotypic assays is another viable drug repositioning strategy.

Purpose of the Study:

• To review methods for generating and validating drug repositioning candidates using in vitro and phenotypic assays.
• To discuss specific examples of drug repositioning across various disease areas.
• To highlight the advantages of in vitro screening for drug repositioning.

Main Methods:

• Focus on in vitro screening of known drugs or drug-like molecules.
• Utilize disease-relevant phenotypic assays for initial screening and validation.
• Review specific examples of applying this approach to different diseases.

Main Results:

• In vitro screens can effectively identify and validate drug repositioning candidates.
• This approach has been successfully applied to diverse disease areas.
• In vitro screening offers advantages over biochemical or in vivo methods.

Conclusions:

• In vitro phenotypic assays are a powerful tool for drug repositioning.
• This strategy facilitates the discovery of new therapeutic applications for existing drugs.
• In vitro screening presents a practical and advantageous starting point for drug repurposing efforts.